News | August 03, 2025
Sandoz to acquire Just–Evotec Biologics facility for $300 million
The companies will now begin detailed contract negotiations and proceed with necessary consultations and approval processes
The companies will now begin detailed contract negotiations and proceed with necessary consultations and approval processes
The submission is supported by results from the Phase 3b APEX study
The request stemmed from a 2024 lawsuit by Rampart alleging Egg Medical had infringed its patent
Bliss GVS Pharma has reported total income of Rs. 242.92 crores during the period ended June 30, 2025
Our specialty chemical businesses have continued to perform strongly, growing double digit YoY
For patients with resectable early-stage gastric and gastroesophageal junction cancers
The Genexus platform enables Next-Generation Sequencing with significantly faster turnaround times
Novo Nordisk will merge its Research & Early Development and Development functions into a single R&D unit
Ajanta Pharma has reported total income of Rs. 1,328.98 crores during the period ended June 30, 2025
The company would be commissioning 3 hubs in Q2 FY26 across our Core Geography and West Bengal
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
